Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Scheen

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Revue Medicale De Liege|March 16, 2023
[A common dilemma in medicine : fortuitous association or causal relationship ?]André Scheen
Revue Medicale De Liege|September 11, 2025
[Tirzepatide (Mounjaro®) : a GIP/GLP-1 receptor dual agonist for the treatment of type 2 diabetes]André Scheen
Revue Medicale De Liege|June 16, 2025
[From clinical practice guidelines to personalized medicine : two guides to be implemented in health care]André Scheen
Revue Medicale De Liege|June 16, 2025
[Gap between guidelines and clinical practice : from epidemiological evidence to solutions to remove barriers]André Scheen
Revue Medicale De Liege|January 16, 2025
[Éditorial. Laissons-nous aller à rêver d'un monde meilleur !]André Scheen
Revue Medicale De Liege|June 13, 2024
[Éditorial. De la médecine curative à la médecine préventive sous tous ses aspects]André Scheen
Revue Medicale De Liege|September 12, 2024
[A new era for incretins : from GLP-1 receptor agonists to co-agonists and poly-agonists]André Scheen
Revue Medicale De Liege|April 17, 2023
[Obesity, type 2 diabetes, metabolic syndrome and depression : a two-way relationship]André Scheen
Revue Medicale De Liege|November 13, 2025
[New paradigm in the management of type 2 diabetes]André Scheen
Revue Medicale De Liege|June 13, 2024
[Prevention of drug iatrogenicity]André Scheen
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Revue Medicale De Liege|March 16, 2023
[A common dilemma in medicine : fortuitous association or causal relationship ?]André Scheen
Revue Medicale De Liege|September 11, 2025
[Tirzepatide (Mounjaro®) : a GIP/GLP-1 receptor dual agonist for the treatment of type 2 diabetes]André Scheen
Revue Medicale De Liege|June 16, 2025
[From clinical practice guidelines to personalized medicine : two guides to be implemented in health care]André Scheen
Revue Medicale De Liege|June 16, 2025
[Gap between guidelines and clinical practice : from epidemiological evidence to solutions to remove barriers]André Scheen
Revue Medicale De Liege|January 16, 2025
[Éditorial. Laissons-nous aller à rêver d'un monde meilleur !]André Scheen
Revue Medicale De Liege|June 13, 2024
[Éditorial. De la médecine curative à la médecine préventive sous tous ses aspects]André Scheen
Revue Medicale De Liege|September 12, 2024
[A new era for incretins : from GLP-1 receptor agonists to co-agonists and poly-agonists]André Scheen
Revue Medicale De Liege|April 17, 2023
[Obesity, type 2 diabetes, metabolic syndrome and depression : a two-way relationship]André Scheen
Revue Medicale De Liege|November 13, 2025
[New paradigm in the management of type 2 diabetes]André Scheen
Revue Medicale De Liege|June 13, 2024
[Prevention of drug iatrogenicity]André Scheen
Pageof 9